Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration

QR Code

Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Dae Gon Ryu, Cheol Woong Choi, Su Jin Kim, Dae Hwan Kang, Su Bum Park
Format:	article
Langue:	EN
Publié:	The Korean Association of Internal Medicine 2021
Sujets:	Medicine R
Accès en ligne:	https://doaj.org/article/7dc520d21483412b82de2f0ffe3d1c67
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
par: Koji Nakajima, et autres
Publié: (2021)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
par: Alexander N Shoushtari, et autres
Publié: (2021)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
par: Giovanni Paolino, et autres
Publié: (2020)

Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
par: Ammar Haikal, et autres
Publié: (2018)

Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
par: Kiyoshi Minohara, et autres
Publié: (2021)

Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
par: Pramod Savarapu, et autres
Publié: (2021)

BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters
par: Aris Spathis, et autres
Publié: (2019)

THE EFFECT OF NIVOLUMAB IN PEDIATRIC MALIGNANT TUMORS: A SINGLE CENTER EXPERIENCE WITH EIGHT PATIENTS
par: Veysel GOK, et autres
Publié: (2021)

Endoscopic semiotics of metastatic bronchial tumors
par: Anna Y. Kontsevaya, et autres
Publié: (2021)

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
par: Tian Zhang, et autres
Publié: (2021)

Maculopapular erythema caused by previously used chemotherapy drugs after nivolumab treatment for malignant mesothelioma
par: Junko Kanai, et autres
Publié: (2021)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
par: Romualdo Barroso-Sousa, et autres
Publié: (2021)

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
par: Morten Fink, et autres
Publié: (2021)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
par: Hiroto Yoneda, et autres
Publié: (2021)

Treatment of Advanced Metastatic Melanoma
par: Pietro Quaglino, et autres
Publié: (2021)

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
par: Matthew D. Tucker, et autres
Publié: (2021)

Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
par: Jiajun Du, et autres
Publié: (2020)

Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
par: Toshiki Kijima, et autres
Publié: (2021)

Arginine deprivation therapy for malignant melanoma
par: Yoon JK, et autres
Publié: (2012)

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
par: Huo Geng-wei, et autres
Publié: (2021)

Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Publié: (2021)

Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
par: Jinah Kim, et autres
Publié: (2011)

Multiregional genetic evolution of metastatic uveal melanoma
par: Daniel A. Rodriguez, et autres
Publié: (2021)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
par: Nobukazu Fujimoto, et autres
Publié: (2021)

Regression of nevi in a melanoma patient treated with interferon
par: Ayelet Rishpon, et autres
Publié: (2012)

Nivolumab-Induced Exocrine Pancreatic Insufficiency
par: Boudewijn Sweep, et autres
Publié: (2021)

Molecular profiling of driver events in metastatic uveal melanoma
par: Joakim Karlsson, et autres
Publié: (2020)

Metastatic melanoma to the ovary in pregnancy: A case report
par: D.S. Huang, et autres
Publié: (2021)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
par: Ryota Tanaka, et autres
Publié: (2021)

Microenvironment-derived factors driving metastatic plasticity in melanoma
par: Isabella S. Kim, et autres
Publié: (2017)

PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
par: Naoya Maekawa, et autres
Publié: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
par: Katsuhiro Yoshimura, MD, PhD, et autres
Publié: (2021)

Use of nivolumab for colon cancer with Lynch syndrome
par: G. A. Khakimov, et autres
Publié: (2020)

The effect of 4-hexylresorinol administration on NAD+ level and SIRT activity in Saos-2 cells
par: In-Song Lee, et autres
Publié: (2021)

Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.
par: Yoana Arroyo-Berdugo, et autres
Publié: (2014)

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
par: Shahneen Sandhu, et autres
Publié: (2021)

Metastatic and non-metastatic melanoma imaging using Sgc8-c aptamer PTK7-recognizer
par: Estefanía Sicco, et autres
Publié: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
par: Mizue Terai, et autres
Publié: (2021)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
par: Jan Pals, et autres
Publié: (2021)

Metastatic melanoma with sebocyte-like melanocytes and widespread visceral involvement
par: Li-Wei Chang, et autres
Publié: (2020)